Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Overview CeramiSphere is a recently incorporated, 100% owned subsidiary of the Australian Nuclear Science and Technology Organisation (ANSTO). CeramiSphere is actively seeking commercial partners to develop and market products using its proprietary encapsulation and controlled release technology for specific market applications. Encapsulation and Controlled Release of Active Molecules ANSTO has developed an expertise in ceramic nanoparticles for encapsulation and controlled release of active molecules, patenting the base technology in 2001. The size of the nanostructured particles can be tailored from 10 nanometres to 100 microns. The release rate can be independently controlled from hours to months. Initially this technology was limited to the encapsulation of small hydrophilic molecules, however, it has recently been expanded to include hydrophobic molecules including hydrophobic oils, biomolecules (including enzymes and DNA) and sequential release technology. Potential applications for this platform technology include delivery of drugs, active ingredients in personal care and cosmetic products, flavour and fragrance encapsulation in food processing, and controlled release of speciality chemicals such as biocides and pesticides for uses in paints and coatings. Key Advantages of CeramiSphere Technologies • • • • • • • • Ambient temperature encapsulation of active molecules inside a ceramic matrix Release rates which can be tailored to specific applications (from mg/hr to mg/month) Variable particle size, from 10nm to 100 µm Particle size and release rate which can be independently varied A ceramic matrix: chemical protection, biocompatible, inert and readily adaptable to most active ingredients Controlled release of hydrophilic and hydrophobic molecules Controlled release of biomolecules including enzymes and DNA Sequential and “delayed” release Collaboration/Partnering Opportunities CeramiSphere is actively seeking commercial partners to develop and market products using its encapsulation and controlled release technology for specific market applications. The CeramiSphere contribution to potential partnerships includes: • • • • Proprietary technology platforms and “know-how” Extensive technical expertise Skilled R&D project teams State of the art resources of a major national research facility, including R&D laboratories, testing and characterisation facilities. For further information please contact: CeramiSphere Pty Ltd PMB 1, Menai NSW 2234 Australia Phone: +61 2 9717 3878 Fax: +61 2 9717 9106 Email: [email protected] CAT No. CRSP106 V.1 www.ceramisphere.com